Side-by-side comparison of Notch- and C83 binding to γ-secretase in a complete membrane model at physiological temperature. Issue 52 (24th August 2020)

• Record Type: Journal Article
• Authors: Dehury, Budheswar; Tang, Ning; Mehra, Rukmankesh; Blundell, Tom L.; Kepp, Kasper P.
• Is Part Of: RSC advances. Volume 10:Issue 52(2020)
• Page Start: 31215
• Page End: 31232
• Publication Date: 2020-08-24
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d0ra04683c
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Distinct membrane dynamics and conformations of C83- and Notch-bound γ-secretase may aid the development of Notch-sparing treatments of Alzheimer's disease. Abstract : γ-Secretase cleaves the C99 fragment of the amyloid precursor protein, leading to formation of aggregated β-amyloid peptide central to Alzheimer's disease, and Notch, essential for cell regulation. Recent cryogenic electron microscopy (cryo-EM) structures indicate major changes upon substrate binding, a β-sheet recognition motif, and a possible helix unwinding to expose peptide bonds towards nucleophilic attack. Here we report side-by-side comparison of the 303 K dynamics of the two proteins in realistic membranes using molecular dynamics simulations. Our ensembles agree with the cryo-EM data (full-protein Cα-RMSD = 1.62–2.19 Å) but reveal distinct presenilin helix conformation states and thermal β-strand to coil transitions of C83 and Notch100. We identify distinct 303 K hydrogen bond dynamics and water accessibility of the catalytic sites. The RKRR motif (1758–1761) contributes significantly to Notch binding and serves as a "membrane anchor" that prevents Notch displacement. Water that transiently hydrogen bonds to G1753 and V1754 probably represents the catalytic nucleophile. At 303 K, Notch and C83 binding induce different conformation states, with Notch mostly present in a closed state with shorter Asp–Asp distance. This may explain the different outcome of Notch and C99 cleavage, as the latter is more imprecise with many products. Our identified conformation states may aid efforts to develop conformation-selective drugs that target C99 and Notch cleavage differently, e.g. Notch-sparing γ-secretase modulators.